Catalyst Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:CPRX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 72.87 M70.88 M60.04 M71.3 M32.44 M44.89 M 208.67 M Cash from investing activities 259 K88 K026 K0-32 K -6 000 Cash from financing activities -5.97 M4.43 M3.06 M872 K4.65 M-25.58 M -16.99 M Free cash flow 72.61 M70.79 M60.04 M71.27 M32.44 M44.86 M 208.61 M

ニュース

オッペンハイマー、売上高予想超えでCatalyst Pharmaceutical株の投資判断を維持

Oppenheimer reiterates Catalyst Pharmaceutical stock rating on revenue beat

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y

成長性への疑問が浮上する中、Catalyst Pharmaceuticalsの決算発表が迫る

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Stock Market Today: Dow Gains As Disney Dives, Pharma Play Eyes Entry, Oracle Pops On This (Live Coverage)

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

Jim Cramer: Crane Is A 'Good' Company, Recommends Holding This Tech Stock - Baker Hughes (NASDAQ:BKR), Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals, Inc. (CPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript